Skip to main content
SpringerLink
Log in

Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

By using a bispecific monoclonal antibody recognising both carcinoembryonic antigen (CEA) and the cytostatic vinca alkaloid drugs we have been able to show specific tumour localisation of vinca alkaloids. In vitro studies with sections of human colorectal tumours have demonstrated that the hybrid-hybrid 28.19.8 monoclonal is able to specifically localise vindesine to cells expressing CEA. Furthermore, the hybrid-hybrid 28.19.8 localises in vivo preferentially to tumour tissues in nude mice bearing the MAWI human xenograft tumour. This tumour-bound hybrid-hybrid monoclonal antibody induces profound changes in the bio-distribution of vinca alkaloid drugs, targeting them specifically to tumour tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arnon R, Sela M (1982) In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumour antibodies. Immunol Rev 62:5

    Google Scholar 

  2. Baldwin RW, Byers VS (eds) (1985) In: Monoclonal antibodies for cancer detection and therapy. Academic Press

  3. Blytham H, Casellas P, Gros O, Gros P, Jansen FK, Paolucci BP, Vidal H (1981) Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells. Nature 290:145

    Google Scholar 

  4. Bumol TF, Wang QC, Reisfeld RA, Kaplan NO (1983) Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumour growth. Proc Natl Acad Sci USA 80:529

    Google Scholar 

  5. Corvalan JRF, Smith W (1987) Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids. Cancer Immunol Immunother 24:127–132

    Google Scholar 

  6. Corvalan JRF, Smith W, Gore VA, Brandon DR, Ryde P (1987) Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody. Cancer Immunol Immunother 24:138–143

    Google Scholar 

  7. Garnett MC, Embleton MJ, Jacobs E, Baldwin RW (1983) Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro. Int J Cancer 31:661

    Google Scholar 

  8. Kanellos J, Pietrsz GA, McKenzie IFC (1985) Studies of methotrexate-monoclonal antibody conjugates for immunotherapy. J Natl Cancer Inst 75:319

    Google Scholar 

  9. Lewis JCM, Smith PA, Keep PA, Boxer GM (1983) A comparison of the content and immunohistochemical patterns of CEA-like activity in human colorectal tumours and nude mouse xenografts. Exp Pathol 24:227

    Google Scholar 

  10. Mason DW, Williams AF (1980) The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem J 187:1

    Google Scholar 

  11. Nisonoff A, Rivers MM, (1961) Recombination of a mixture of univalent antibody fragments of different specificity. Arch Biochem Biophs 93:460

    Google Scholar 

  12. Pimm MV, Armitage NC, Perkins AC, Smith W, Baldwin RW (1985) Localisation of an anti-CEA monoclonal antibody in colorectal carcinoma xenograft. Cancer Immunol Immunother 19:8

    Google Scholar 

  13. Raso V (1982) Antibody mediated delivery of toxic molecules to antigen bearing target cells. Immunol Rev 62:93

    Google Scholar 

  14. Raso V, Griffin T (1981) Hybrid antibodies with dual specificity for the delivery of ricin to immunoglobulin-bearing targets. Cancer Res 41:2073

    Google Scholar 

  15. Rowland GF, Simmonds RG, Corvalan JRF, Baldwin RW, Brown JP, Embleton MJ, Ford CH, Hellstrom KE, Hellstrom I, Kempshead JT, Newman CE, Woodhouse CS (1983) Monoclonal antibodies for targeted therapy with vindesine 30: 375

  16. Rowland GF, Corvalan JRF, Axton CA, Gore VA, Marsden CH, Smith W, Simmonds RG (1984) Suppression of growth of a human colorectal tumour in nude mice by vindesinemonoclonal anti-CEA conjugates. Protides of the Biol Fluids 31:783

    Google Scholar 

  17. Rowland GF, Axton CA, Baldwin RW, Brown JP, Corvalan JRF, Embleton MJ, Gore VA, Hellstrom I, Hellstrom KE, Jacobs E, Marsden CH, Pimm MV, Simmonds RG, Smith W (1985) Antitumour properties of vindesine-monoclonal antibody conjugates. Cancer Immunol Immunother 19:1

    Google Scholar 

  18. Rowland GF, Simmonds RG, Gore VA, Marsden CH, Smith W (1986) Drug localisation and growth inhibition studies of vindesine-monoclonal anti-CEA conjugates in a human tumour xenograft. Cancer Immunol Immunother 21:183

    Google Scholar 

  19. Simmonds RG, Smith W, Corvalan JRF (1984) Affinity purification of anti-CEA antibody. Protides of the Biol Fluids 31:917

    Google Scholar 

  20. Thorpe PE, Brown ANF, Bremner JAG, Foxwell BMJ, Stirpe F (1985) An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: Potent antitumour murine effects in vitro and in vivo. J Natl Cancer Inst 75:151

    Google Scholar 

  21. Vitteta ES, Krolick KA, Miyama-Inaba M, Cushley W, Uhr JW (1983) Immunotoxins: A new approach to cancer therapy. Science 219:644

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lilly Research Centre Ltd., Eli Lilly & Co., Erl Wood Manor, GU20 6PH, Windlesham, Surrey, U.K.

    J. R. F. Corvalan, W. Smith, V. A. Gore & D. R. Brandon

Authors
  1. J. R. F. Corvalan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. A. Gore
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. R. Brandon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corvalan, J.R.F., Smith, W., Gore, V.A. et al. Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids. Cancer Immunol Immunother 24, 133–137 (1987). https://doi.org/10.1007/BF00205590

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205590

Keywords

Search

Navigation